Literature DB >> 28266708

Role of Wnt/β-catenin signaling regulatory microRNAs in the pathogenesis of colorectal cancer.

Farzad Rahmani1, Amir Avan2,3, Seyed Isaac Hashemy4, Seyed Mahdi Hassanian1,5,6.   

Abstract

Colorectal cancer (CRC) is one of the leading causes of cancer death worldwide. In more than 90% of all CRC patients, the master oncogenic Ras-Wnt signaling axis is over-activated. MicroRNAs (miRNAs) are potential novel diagnostic and prognostic biomarkers as well as therapeutic targets for several cancers including lung, breast, gastric, and colorectal cancers. Oncogenic or tumor suppressor miRNAs modulate tumor cells proliferation, cell cycle progression, angiogenesis, invasion, and metastasis through regulating oncogenic pathways including Wnt/β-catenin signaling. This review summarizes the current knowledge about the role of Wnt/β-catenin signaling regulatory miRNAs in the pathogenesis of colorectal cancer for a better understanding and hence a better management of this disease.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  Wnt/β-catenin signaling; colorectal cancer; microRNA

Mesh:

Substances:

Year:  2017        PMID: 28266708     DOI: 10.1002/jcp.25897

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  24 in total

1.  MiR-195 suppresses colon cancer proliferation and metastasis by targeting WNT3A.

Authors:  Baoyu Li; Shunsheng Wang; Shumei Wang
Journal:  Mol Genet Genomics       Date:  2018-06-09       Impact factor: 3.291

Review 2.  Cancer stem cells in colorectal cancer and the association with chemotherapy resistance.

Authors:  Xue Lei; Qinglian He; Ziqi Li; Qian Zou; Pingrong Xu; Haibing Yu; Yuanlin Ding; Wei Zhu
Journal:  Med Oncol       Date:  2021-03-18       Impact factor: 3.064

Review 3.  Stem Cell-based Therapy Strategy for Hepatic Fibrosis by Targeting Intrahepatic Cells.

Authors:  Yaxin Deng; Bin Xia; Zhongmin Chen; Fuping Wang; Yonggang Lv; Guobao Chen
Journal:  Stem Cell Rev Rep       Date:  2021-10-19       Impact factor: 5.739

Review 4.  The emerging role of substance P/neurokinin-1 receptor signaling pathways in growth and development of tumor cells.

Authors:  Hossein Javid; Fariba Mohammadi; Elnaz Zahiri; Seyed Isaac Hashemy
Journal:  J Physiol Biochem       Date:  2019-08-01       Impact factor: 4.158

5.  Profiles of differentially expressed genes and overexpression of NEBL indicates a positive prognosis in patients with colorectal cancer.

Authors:  Xiao Qiu; Jue-Rong Feng; Fan Wang; Peng-Fei Chen; Xiao-Xing Chen; Rui Zhou; Ying Chang; Jing Liu; Qiu Zhao
Journal:  Mol Med Rep       Date:  2017-12-07       Impact factor: 2.952

Review 6.  TRAIL, Wnt, Sonic Hedgehog, TGFβ, and miRNA Signalings Are Potential Targets for Oral Cancer Therapy.

Authors:  Ammad Ahmad Farooqi; Chih-Wen Shu; Hurng-Wern Huang; Hui-Ru Wang; Yung-Ting Chang; Sundas Fayyaz; Shyng-Shiou F Yuan; Jen-Yang Tang; Hsueh-Wei Chang
Journal:  Int J Mol Sci       Date:  2017-07-14       Impact factor: 5.923

7.  Identification of the miRNA-mRNA regulatory network of small cell osteosarcoma based on RNA-seq.

Authors:  Lin Xie; Yedan Liao; Lida Shen; Fengdi Hu; Sunlin Yu; Yonghong Zhou; Ya Zhang; Yihao Yang; Dongqi Li; Minyan Ren; Zhongqin Yuan; Zuozhang Yang
Journal:  Oncotarget       Date:  2017-06-27

8.  Knockdown of LETM1 inhibits proliferation and metastasis of human renal cell carcinoma cells.

Authors:  Jie Xu; Bisheng Huang; Saiyang Li; Xiaolu Zhang; Tiancheng Xie; Yunfei Xu
Journal:  Oncol Lett       Date:  2018-09-18       Impact factor: 2.967

9.  Interplay of miRNAs and Canonical Wnt Signaling Pathway in Hepatocellular Carcinoma.

Authors:  Xiaobo Nie; Yiran Liu; Wei-Dong Chen; Yan-Dong Wang
Journal:  Front Pharmacol       Date:  2018-06-21       Impact factor: 5.810

10.  MicroRNA-144 mediates chronic inflammation and tumorigenesis in colorectal cancer progression via regulating C-X-C motif chemokine ligand 11.

Authors:  Bin Han; Dan Feng; Xin Yu; Yuanqi Liu; Ming Yang; Fei Luo; Liming Zhou; Fu Liu
Journal:  Exp Ther Med       Date:  2018-07-02       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.